Get startedLog in
    Picture of PolyPeptide AG logo

    PPGN — PolyPeptide AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Brief: Samsung Biologics To Buy Polypeptide For Chf 44.31 Per Share, Equity Value CHF 1.46 Billion

    Picture of PolyPeptide AG logoPolyPeptide AG
    19/07/2026 23:49
    BRIEF-Samsung Biologics To Buy Polypeptide For Chf 44.31 Per Share, Equity Value CHF 1.46 Billion
    July 19 (Reuters) - Samsung Biologics Co Ltd 207940.KS:
    • SAMSUNG BIOLOGICS ANNOUNCES ALL-CASH OFFER TO ACQUIRE POLYPEPTIDE, ACCELERATING MULTI-MODALITY STRATEGY AND EXPANDING GLOBAL NETWORK ACROSS U.S., EUROPE, AND INDIA
    • SAMSUNG BIOLOGICS CO - TO BUY POLYPEPTIDE FOR CHF 44.31 PER SHARE, EQUITY VALUE CHF 1.46 BILLION
    • SAMSUNG BIOLOGICS CO - POLYPEPTIDE BOARD UNANIMOUSLY RECOMMENDS OFFER
    Source text: ID:nPnbbcWLpa
    Further company coverage: [207940.KS PPGN.S]

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on PolyPeptide AG

    See all news